ATLAS fair value
ATLAS has no fair value for this stock today.
RPG Life Sciences share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
Prices as of Oct 26, 2026 · INR
ATLAS has no fair value for this stock today.
49%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives RPG Life Sciences a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹2,546 and ₹2,979; in 9 out of 10, between ₹2,214 and ₹3,425. Estimated annual volatility is 47%.
ATLAS does not publish a fair value for RPGLIFE.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks RPGLIFE.NSE has traded between ₹1,733 and ₹3,128. Today it is 11.7% below that high and 59% above its low.
On the business: net margin is 16.3%; it trades at 40.3 times earnings.
Its beta is -0.13: it tends to move less than the market.
RPG Life Sciences Ltd. is a prominent player in the pharmaceutical industry, specializing in the development, manufacture, and marketing of a wide range of pharmaceutical products.
Want to see everything about RPG Life Sciences?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
RPG Life Sciences Ltd. is a prominent player in the pharmaceutical industry, specializing in the development, manufacture, and marketing of a wide range of pharmaceutical products.
49%: close to a coin flip. In half of the simulated outcomes, RPGLIFE.NSE ends the month between ₹2,546 and ₹2,979.
RPG Life Sciences's market capitalization is ₹47.0B. Its price-to-earnings (P/E) ratio is 40.3: you pay ₹40.3 for each ₹1.00 of yearly earnings.
Yes. RPGLIFE.NSE's current dividend yield is 3.38% at today's price (₹2,762).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy